Patanase

Active Ingredient(s): Olopatadine Hydrochloride
FDA Approved: * April 15, 2008
Pharm Company: * ALCON RES
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Patanase Overview

Olopatadine is an antihistamine (as well as anticholinergic and mast cell stabilizer), sold as a prescription eye drop manufactured by Alcon in one of three strengths: 0.7% solution or Pazeo in the United States, 0.2% solution or Pataday (also called Patanol S in some countries), and 0.1% or Patanol (also called Opatanol in some countries; Olopat in India). It is used to treat itching associated with allergic conjunctivitis (eye allergies).[1] A steroid-free[2]...

Read more Patanase Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Olopatadine

Recent Patanase Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Olopatadine Hydrochloride
  • Solution: 0.1%, 0.2%
  • Solution/drops: 0.1%
  • Spray: 0.6%
  • Spray, Metered: 0.665mg/spray
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Patanase: (3 results)

Sorted by National Drug Code
  • 0065-0332 Patanase 665 ug/1 Nasal Spray, Metered by Alcon Laboratories, Inc.
  • 54868-6049 Patanase 665 ug/1 Nasal Spray, Metered by Physicians Total Care, Inc.
  • 58118-9924 Patanase 665 ug/1 Nasal Spray, Metered by Clinical Solutions Wholesale

Other drugs which contain Olopatadine Hydrochloride or a similar ingredient: (2 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 24 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA